IPCA Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Access Capital Limited
Equibles does not estimate personal net worth.
Kunal is recorded as Analyst at Access Capital Limited. Kunal has spoken on 2 earnings calls across 2 companies, most recently for IPCA Laboratories Limited on August 14, 2026. Those appearances were for IPCA Laboratories Limited and Krishna Institute of Medical Sciences Limited. The companies whose calls Kunal spoke on are classified in the Healthcare sector.
“Sir, firstly on the U.S. business, if you mind giving us some color on what we can expect for the next one to two years, maybe some sense of the number of launches, both from IPCA's table as well as from Unicam.”
“The first question is on the Kondapur unit. So I just want to understand the revenue potential from this. This has been a fairly lucrative unit for you, 350 crores plus revenue, 100 crores plus EBEDDA.”
Access Capital Limited
Analyst
Transcript header (unverified)
IPCA Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Krishna Institute of Medical Sciences Limited
Medical Care Facilities · Healthcare
Earnings Call
IPCA Laboratories Limited
Earnings Call
Krishna Institute of Medical Sciences Limited